Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Urban Air Pollution Linked to Birth Defects

By Biotechdaily staff writers
Posted on 20 May 2002
A study has provided the first evidence that pregnant women exposed to increased levels of ozone and carbon monoxide have an elevated risk of having a child with heart defects.
The study was conducted by researchers from the University of California, Los Angeles, School of Public Health (UCLA, USA) and the California Birth Defects Monitoring Program (CBDMP). More...
The findings were published in the January 1, 2002, issue of the American Journal of Epidemiology.

The researchers analyzed information on more than 9,000 babies born from 1987 to 1993 in four California counties. They compared air quality near the homes of children born with birth defects to air quality in the neighborhoods of children born healthy, using measurements made regularly at 30 locations by the South Coast Air Quality Management District.

The results showed that pregnant women exposed to increased levels of ozone and carbon monoxide in the second month of pregnancy, when the heart and other organs begin developing, had an elevated risk of having a child with conotruncal heart defects, pulmonary artery/valve defects, and aortic artery/valve defects. This group of defects was shown to occur 1.76 times per 1,000 births, resulting in 935 cases in California each year. Many of these babies face open-heart surgery before the age of one. Moreover, the risk of having a child with these defects tripled for those women living in areas with the highest levels of the two pollutants in comparison with women living in areas with the cleanest air. Although there has been a significant decrease in US urban air pollution, the study suggests there may be pollution problems and health risks not yet understood.

"These findings show that there are more health problems caused by air pollution than solely asthma and other respiratory illnesses,” said Beate Ritz, a UCLA epidemiologist who led the study.




Related Links:
UCLA

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.